This Month in Pharmacist’s Letter:
SGLT2 Inhibitors for Patients WithOUT Diabetes
You’ll start to see more patients withOUT diabetes using SGLT2 inhibitors like Invokana for heart failure or kidney disease. Growing evidence suggests these meds may improve outcomes when added to standard therapy.
Two new studies add to existing data. You’ll see SGLT2 inhibitors suggested in upcoming heart failure and CKD guidelines, and they may get new indications.
Read more in this month’s Pharmacist’s Letter article, including recommendations and what to look out for when dispensing SGLT2 inhibitors for patients without diabetes.
Hospital Pharmacists: Check out this month’s Hospital Pharmacist’s Letter article: Understand Roles of Remdesivir and Dexamethasone for COVID-19
This Month in Prescriber’s Letter:
Common Questions About VTE Treatment
Questions are coming up about TREATING venous thromboembolism (VTE), including:
- Which anticoagulant is preferred?
- How long should anticoagulation be used?
- When might a LOW-dose DOAC be considered long-term?
- What should you do if a patient has a VTE on anticoagulation?
Get answers to these, plus reference a handy chart in this month’s Prescriber’s Letter article.
This Month in Pharmacy Technician’s Letter:
Technician Opportunity to Give Vaccines
More pharmacy technicians will give immunizations to help expand access to vaccines during COVID-19.
Now federal guidance authorizes qualified pharmacy technicians in all states to give childhood vaccines (DTaP, flu, HPV, etc) to kids age 3 to 18, and COVID-19 vaccines to people age 3 and up.
The goal is to offset a drop in pediatric vaccination rates and to help meet potential demand for COVID-19 vaccines.
This is a BIG opportunity for pharmacy technicians. Get more info about giving vaccines, including what to expect and how to get trained, plus a tutorial called The Basics of Immunization and Vaccines in this month’s Pharmacy Technician’s Letter article.
Want more info like this?
TRC Letters monthly notifications keep clinicians and professionals ahead of the latest drug therapy and medication findings. Sign up today to receive monthly alerts via email when each new issue is available. Choose a Letter product below to get a preview of the new articles, clinical resources and recommendations included in the December 2020 issues. Learn which emerging topics require practice changing updates; and stay abreast of the new pharmacology CE/CME, drug charts, and patient education handouts that are available this month.
To receive TRC Letters monthly email notifications directly to your inbox each month, click below.